Conception has achieved what many researchers considered impossible: generating human egg cells from stem cells in laboratory conditions. The company's work builds on 2016 mouse studies where skin cells were converted into functional eggs that produced healthy offspring. This milestone represents the first successful attempt at human in vitro gametogenesis, a field that has struggled to replicate animal results in humans.

Rather than pursuing shortcuts, Conception's approach reconstructs the complete natural development sequence. Researchers extract blood cells, convert them to induced pluripotent stem cells, then guide differentiation into primordial germ cells and ovarian helper cells. These combine into three-dimensional mini-ovaries that mimic human ovarian structure. The company generates thousands of these structures simultaneously, containing millions of potential egg cells for parallel study and optimization.

The breakthrough validates at multiple stages. Mini-ovaries self-organize into nests resembling natural ovarian architecture. Cells progress through meiosis correctly, with chromosome-pairing machinery assembling as expected. Most significantly, researchers have created what they believe are the first fully stem cell-derived human follicles - the essential ovarian units housing each egg. These structures show proper cellular organization without artificial manipulation.

This achievement could transform fertility treatment by eliminating hormone injections and surgical retrieval. Families might access unlimited healthy eggs from simple blood draws, enabling older women to conceive naturally. However, the work remains years from clinical application, with safety and efficacy questions still requiring extensive study before human trials.